Karyopharm Therapeutics Cost of Goods Sold 2012-2024 | KPTI
Karyopharm Therapeutics cost of goods sold from 2012 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.